Ruikun Du

shandong university of traditional chinese medicine

H指数:20

被引数:1,381

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Isolation of Rhizoma Paridis saponins as novel entry inhibitors of Crimean-Congo hemorrhagic fever virus

从重楼皂苷中分离出克里米亚-刚果出血热病毒的新型进入抑制剂

Cell Insight

IF0

2026-06-011

OAAI

Identification of FDA-approved IMPDH inhibitors boosting the broad-spectrum antiviral potential of ribavirin through depleting cellular GTP pool

通过耗竭细胞GTP池鉴定可增强利巴韦林广谱抗病毒潜力的FDA批准的IMPDH抑制剂

Acta Pharmaceutica Sinica B

IF14.6

2026-05-200

OAAI

In vivo evaluation and material basis of the bi-directional immune modulatory effect of Scutellaria barbata D. Don extract

体内评价及Scutellaria barbata D. Don提取物的双向免疫调节效应的物质基础

Frontiers in Medicine

IF3

2026-04-070

OAAI

Yupingfeng Formula Exerts Antiviral Property by Promoting IFN-I Production and IgG1 Antibody Response

玉屏风方通过促进IFN-I产生和IgG1抗体应答发挥抗病毒作用。

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2025-11-260

PRE

Generation and Characterization of a CE1-Modified mCherry-Expressing Influenza A Virus for In Vivo Imaging and Antiviral Drug Evaluation

生成并表征一种用于体内成像和抗病毒药物评价的CE1修饰的mCherry表达性甲型流感病毒

Viruses 2025, Vol. 17, Page 1537

IF3.5

2025-11-240

OAAI

Balancing Host Defense and Viral Tolerance for the Development of Next-Generation Broad-Spectrum Antiviral Agents

平衡宿主防御与病毒耐受性，以开发下一代广谱抗病毒药物

Pathogens 2025, Vol. 14, Page 911

IF0

2025-09-100

Kaempferide enhances type I interferon signaling as a novel broad-spectrum antiviral agent

Kaempferide 作为一种新型广谱抗病毒剂，能够增强 I 型干扰素信号通路。

ANTIVIRAL RESEARCH

IF4

2025-05-010

PRE

Antiviral effects and mechanism of Qi pi pill against influenza viruses

芪脾丸抗流感病毒作用及机制研究

ANIMAL MODELS AND EXPERIMENTAL MEDICINE

IF3.4

2025-01-260

OAAI

A BSL-2 compliant mouse model of SARS-CoV-2 infection for efficient and convenient antiviral evaluation

JOURNAL OF VIROLOGY

IF3.8

2024-07-230

PRE

Material basis and pharmacodynamic mechanism of YangshenDingzhi granules in the intervention of viral pneumonia: Based on serum pharmacochemistry and network pharmacology

ANIMAL MODELS AND EXPERIMENTAL MEDICINE

IF3.4

2024-06-111

OAAI

Development of a virus-based affinity ultrafiltration method for screening virus-surface-protein-targeted compounds from complex matrixes: Herbal medicines as a case study

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2024-03-132

An orally active entry inhibitor of influenza A viruses protects mice and synergizes with oseltamivir and baloxavir marboxil

SCIENCE ADVANCES

IF12.5

2024-02-234

OAAI

Paving new roads toward the advancement of broad-spectrum antiviral agents

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2024-01-051

PRE

Influenza virus cell entry and targeted antiviral development

流感病毒细胞进入和靶向抗病毒药物的发展

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2023-11-061

PRE

Licochalcone A plays dual antiviral roles by inhibiting RSV and protecting against host damage

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2023-08-273

PRE

Discovery of ligustrazine and chalcone derivatives as novel viral nucleoprotein nuclear export inhibitors against influenza viruses

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2023-07-253

PRE

Sulforaphane is a reversible covalent inhibitor of 3-chymotrypsin-like protease of SARS-CoV-2

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2023-03-055

PRE

Development of an HiBiT-tagged reporter H3N2 influenza A virus and its utility as an antiviral screening platform

HiBiT标记的报告基因H3N2甲型流感病毒的开发及其作为抗病毒筛选平台的实用性

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2022-12-027

PRE

Expanding the tolerance of segmented Influenza A Virus genome using a balance compensation strategy

PLOS PATHOGENS

IF4.9

2022-08-0414

OAAI

SARS-CoV-2 cell entry and targeted antiviral development

SARS-CoV-2细胞进入和靶向抗病毒药物的发展

ACTA PHARMACEUTICA SINICA B

IF14.6

2021-12-0124

OAAI

Ruikun Du

个人简介

教育背景

工作经历

荣誉奖项

研究方向